KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+5.58%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$279M
AUM Growth
+$279M
(+0.79%)
Cap. Flow
-$8.17M
Cap. Flow
% of AUM
-2.93%
Top 10 Holdings %
Top 10 Hldgs %
85.6%
Holding
18
New
1
Increased
11
Reduced
4
Closed
2
Top Buys
| 1 |
Gilead Sciences
GILD
|
$30.1M |
| 2 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$2.87M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$1.88M |
| 4 |
IVC
Invacare Corporation
IVC
|
$776K |
| 5 |
Orthofix Medical
OFIX
|
$205K |
Top Sells
| 1 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$24.5M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$18.3M |
| 3 |
United Therapeutics
UTHR
|
$696K |
| 4 |
Avanos Medical
AVNS
|
$425K |
| 5 |
Merck
MRK
|
$303K |
Sector Composition
| 1 | Healthcare | 79.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $38.9M | 13.93% | 270,909 -4,855 | -2% | -$696K |
|
|
2
Enanta Pharmaceuticals
ENTA
$180M
| $35.4M | 12.68% | 1,055,719 +55,978 | +6% | +$1.88M |
|
|
3
Gilead Sciences
GILD
$140B
| $30.1M | 10.78% | +420,000 | New | +$30.1M |
|
|
SCMP
4
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $25.3M | 9.05% | 1,863,755 +211,857 | +13% | +$2.87M |
|
|
5
Orthofix Medical
OFIX
$592M
| $23.4M | 8.37% | 645,530 +5,679 | +0.9% | +$205K |
|
|
6
Avanos Medical
AVNS
$554M
| $20.9M | 7.49% | 564,792 -11,493 | -2% | -$425K |
|
7
Amgen
AMGN
$155B
| $18.6M | 6.67% | 127,157 +1,119 | +0.9% | +$164K |
|
|
8
Merck
MRK
$210B
| $14.9M | 5.34% | 252,874 -5,147 | -2% | -$303K |
|
9
CONMED
CNMD
$1.68B
| $14.5M | 5.21% | 328,677 +2,892 | +0.9% | +$128K |
|
|
IVC
10
DELISTED
Invacare Corporation
IVC
| $14.4M | 5.16% | 1,102,586 +59,475 | +6% | +$776K |
|
|
SRGA
11
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $13.7M | 4.91% | 4,216,948 +35,857 | +0.9% | +$117K |
|
|
DSCI
12
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $4.63M | 1.66% | 891,026 +7,026 | +0.8% | +$36.5K |
|
|
VXRT
13
DELISTED
Vaxart
VXRT
| $3.37M | 1.21% | 2,737,602 +24,085 | +0.9% | +$29.6K |
|
|
STRR
14
DELISTED
Star Equity Holdings
STRR
| $2.43M | 0.87% | 486,400 +4,279 | +0.9% | +$21.4K |
|
|
JNP
15
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.63M | 0.58% | 290,853 +2,559 | +0.9% | +$14.3K |
|
|
IPXL
16
DELISTED
Impax Laboratories, Inc.
IPXL
| – | – | -1,032,187 | Closed | -$24.5M |
|
|
17
Teva Pharmaceuticals
TEVA
$21.1B
| – | – | -397,412 | Closed | -$18.3M |
|